Peripheral blood mononuclear cells from mild cognitive impairment patients show deregulation of Bax and Sod1 mRNAs

Neuroscience Letters

Volumn 453, Issue 1, 2009, Pages 36-40

  Gatta, Lucia ^a   Cardinale, Alessio ^a   Wannenes, Francesca ^a,b   Consoli, Claudia ^c   Armani, Andrea ^a,b   Molinari, Francesca ^a   Mammi, Caterina ^a   Stocchi, Fabrizio ^a   Torti, Margherita ^a   Rosano, Giuseppe M C ^c   Fini, Massimo ^a  

^a IRCCS SAN RAFFAELE PISANA   (Italy)

^b CNR   (Italy)

^c San Raffaele Sulmona ^*  (Italy)

Author keywords

Alzheimer's disease; Apoptosis; Mild cognitive impairment; Peripheral blood mononuclear cells

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; HYDROGEN PEROXIDE; MEMBRANE PROTEIN; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2; PROTEIN PARP; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME REGULATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; OXIDATIVE STRESS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; COGNITION DISORDERS; COLLAGEN TYPE XI; FEMALE; GENE EXPRESSION; HUMANS; HYDROGEN PEROXIDE; LEUKOCYTES, MONONUCLEAR; MALE; OXIDANTS; PARKINSON DISEASE; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; SUPEROXIDE DISMUTASE;

EID: 61449196575     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.02.003     Document Type: Article

References (24)

1. Bermejo P., Martin-Aragon S., Benedi J., Susin C., Felici E., Gil P., Ribera J.M., and Villar A.M. Peripheral levels of glutathione and protein oxidation as markers in the development of Alzheimer's disease from Mild Cognitive Impairment. Free Radic. Res. 42 (2008) 162-170
2. Boll M.C., Alcaraz-Zubeldia M., Montes S., and Rios C. Free copper, ferroxidase and SOD1 activities, lipid peroxidation and NO(x) content in the CSF. A different marker profile in four neurodegenerative diseases. Neurochem. Res. 33 (2008) 1717-1723
3. Borroni B., Di Luca M., and Padovani A. Predicting Alzheimer dementia in mild cognitive impairment patients. Are biomarkers useful?. Eur. J. Pharmacol. 545 (2006) 73-80
4. Callahan C.M., Hall K.S., Hui S.L., Musick B.S., Unverzagt F.W., and Hendrie H.C. Relationship of age, education, and occupation with dementia among a community-based sample of African Americans. Arch. Neurol. 53 (1996) 134-140
5. Cova E., Cereda C., Galli A., Curti D., Finotti C., Di Poto C., Corato M., Mazzini G., and Ceroni M. Modified expression of Bcl-2 and SOD1 proteins in lymphocytes from sporadic ALS patients. Neurosci. Lett. 399 (2006) 186-190
6. de la Monte S.M., Neely T.R., Cannon J., and Wands J.R. Oxidative stress and hypoxia-like injury cause Alzheimer-type molecular abnormalities in central nervous system neurons. Cell Mol. Life Sci. 57 (2000) 1471-1481
7. Eckert A., Cotman C.W., Zerfass R., Hennerici M., and Muller W.E. Enhanced vulnerability to apoptotic cell death in sporadic Alzheimer's disease. Neuroreport 9 (1998) 2443-2446
8. Eckert A., Oster M., Zerfass R., Hennerici M., and Muller W.E. Elevated levels of fragmented DNA nucleosomes in native and activated lymphocytes indicate an enhanced sensitivity to apoptosis in sporadic Alzheimer's disease. Specific differences to vascular dementia. Dement. Geriatr. Cogn. Disord. 12 (2001) 98-105
9. Floyd R.A., and Hensley K. Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases. Neurobiol. Aging 23 (2002) 795-807
10. Frey C., Bonert A., Kratzsch T., Rexroth G., Rosch W., Muller-Spahn F., Maurer K., Muller W.E., and Eckert A. Apolipoprotein E epsilon 4 is associated with an increased vulnerability to cell death in Alzheimer's disease. J. Neural Transm. 113 (2006) 1753-1761
11. Frisoni G.B., Padovani A., and Wahlund L.O. The predementia diagnosis of Alzheimer disease. Alzheimer Dis. Assoc. Disord. 18 (2004) 51-53
12. Ghiso J., and Frangione B. Amyloidosis and Alzheimer's disease. Adv. Drug Deliv. Rev. 54 (2002) 1539-1551
13. Gibson G.E., and Huang H.M. Oxidative stress in Alzheimer's disease. Neurobiol. Aging 26 (2005) 575-578
14. Herceg Z., and Wang Z.Q. Failure of poly(ADP-ribose) polymerase cleavage by caspases leads to induction of necrosis and enhanced apoptosis. Mol. Cell Biol. 19 (1999) 5124-5133
15. Leuner K., Pantel J., Frey C., Schindowski K., Schulz K., Wegat T., Maurer K., Eckert A., and Muller W.E. Enhanced apoptosis, oxidative stress and mitochondrial dysfunction in lymphocytes as potential biomarkers for Alzheimer's disease. J. Neural Transm. Suppl. 72 (2007) 207-215
16. Licastro F., Pedrini S., Caputo L., Annoni G., Davis L.J., Ferri C., Casadei V., and Grimaldi L.M. Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?. J. Neuroimmunol. 103 (2000) 97-102
17. Luis C.A., Loewenstein D.A., Acevedo A., Barker W.W., and Duara R. Mild cognitive impairment: directions for future research. Neurology 61 (2003) 438-444
18. Migliore L., Fontana I., Colognato R., Coppede F., Siciliano G., and Murri L. Searching for the role and the most suitable biomarkers of oxidative stress in Alzheimer's disease and in other neurodegenerative diseases. Neurobiol. Aging 26 (2005) 587-595
19. Migliore L., Fontana I., Trippi F., Colognato R., Coppede F., Tognoni G., Nucciarone B., and Siciliano G. Oxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patients. Neurobiol. Aging 26 (2005) 567-573
20. Moreira P.I., Zhu X., Nunomura A., Smith M.A., and Perry G. Therapeutic options in Alzheimer's disease. Expert. Rev. Neurother. 6 (2006) 897-910
21. Petersen R.C., Doody R., Kurz A., Mohs R.C., Morris J.C., Rabins P.V., Ritchie K., Rossor M., Thal L., and Winblad B. Current concepts in mild cognitive impairment. Arch. Neurol. 58 (2001) 1985-1992
22. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., and Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol. 56 (1999) 303-308
23. Rinaldi P., Polidori M.C., Metastasio A., Mariani E., Mattioli P., Cherubini A., Catani M., Cecchetti R., Senin U., and Mecocci P. Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease. Neurobiol. Aging 24 (2003) 915-919
24. Rossor M.N., Newman S., Frackowiak R.S., Lantos P., and Kennedy A.M. Alzheimer's disease families with amyloid precursor protein mutations. Ann. N. Y. Acad. Sci. 695 (1993) 198-202